Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ImmunityBio, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-09 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-09
Exact text from the filing
2. Ratification of Appointment of Independent Registered Public Accounting Firm. The appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified by our stockholders based on the following results of voting: Votes “For” Votes “Against” Abstentions “Broker Non-Votes” 882,420,139 1,675,960 1,070,960 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ImmunityBio, Inc. shareholders approved Election of Nine Directors at the 2026-06-09 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-09
Exact text from the filing
1. Election of Nine Directors. The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one year term expiring at the 2027 annual meeting of stockholders based on the following results of voting. Each director's term continues until the election and qualification of his or her successor, or until his or her earlier retirement, resignation, disqualification, removal, or death. Nominee Votes “For” Votes “Withheld” “Broker Non-Votes” Patrick Soon-Shiong, M.D. 714,631,732 19,014,153 151,521,174 Cheryl L. Cohen 731,554,649 2,091,236 151,521,174 Richard Adcock 731,960,821 1,685,064 151,521,174 Michael D. Blaszyk 722,575,150 11,070,735 151,521,174 Wesley Clark 729,527,285 4,118,600 151,521,174 Linda Maxwell, M.D. 717,976,024 15,669,861 151,521,174 Christobel Selecky 722,387,537 11,258,348 151,521,174 Barry J. Simon, M.D. 731,770,436 1,875,449 151,521,174 Bruce Wendel 732,149,734 1,496,151 151,521,174
View on SEC.gov